Franklin Genomic Advancements ETF Rating $39.77 -1.06 (-2.60%) Closing price 11/20/2026 04:10 PM EasternExtended Trading$39.81 +0.04 (+0.10%) As of 11/20/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HELX Aggregate RatingModerate Buy 2.77Holdings in HELX have an aggregate rating of Moderate Buy based on 423 analyst ratings issued in the past year covering 24 companies (72.5% of the portfolio).HELX Aggregate Price Target$39.77High Prediction$39.77Average Prediction$39.77Low Prediction$39.77Holdings in HELX have an aggregate price target of $39.77 and a range of $39.77 to $39.77 covering 24 companies (72.5% of the portfolio).HELX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Franklin Genomic Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 HELX Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings8.56%GHGuardant Health$145.83+0.2%Moderate Buy$191.48 31.3%263.7592 of 5 starsTrending NewsAnalyst ForecastInsider Trade8.02%NTRANatera$273.08-5.8%Moderate Buy$396.93 45.4%232.8666 of 5 starsAnalyst Forecast5.08%ADPTAdaptive Biotechnologies$27.90-0.5%Moderate Buy$30.31 8.6%82.2316 of 5 starsGap Down4.80%KRYSKrystal Biotech$308.58-2.3%Moderate Buy$375.00 21.5%143.2896 of 5 stars4.61%LGNDLigand Pharmaceuticals$286.870.0%Moderate Buy$355.38 23.9%93.7715 of 5 stars3.41%BBIOBridgeBio Pharma$76.03-2.8%Moderate Buy$104.42 37.3%222.8328 of 5 starsInsider Trade3.39%TWSTTwist Bioscience$103.23-7.5%Hold$133.92 29.7%122.7769 of 5 starsGap Down2.87%MEDPMedpace$609.38-3.9%Hold$649.27 6.5%132.8585 of 5 stars2.81%LLYEli Lilly and Company$1,346.40-0.3%Moderate Buy$1,422.00 5.6%303.9509 of 5 starsTrending NewsAnalyst Forecast2.78%UTHRUnited Therapeutics$554.73-0.8%Moderate Buy$676.40 21.9%164.6357 of 5 starsTrending NewsInsider Trade2.76%VRTXVertex Pharmaceuticals$514.76-1.1%Moderate Buy$596.44 15.9%283.7978 of 5 starsInsider Trade2.52%REGNRegeneron Pharmaceuticals$920.69-0.3%Moderate Buy$904.41 -1.8%313.7486 of 5 starsTrending NewsAnalyst ForecastInsider Trade2.40%TVTXTravere Therapeutics$46.99-2.7%Moderate Buy$72.55 54.4%133.6695 of 5 starsAnalyst Upgrade2.15%VYLRVylor$68.11+0.5%Moderate Buy$82.54 21.2%163.8125 of 5 starsAnalyst ForecastHigh Trading Volume2.12%TEMTempus AI$53.98-9.5%Hold$79.37 47.0%223.1188 of 5 starsTrending NewsAnalyst ForecastInsider TradeGap Up2.12%CDNACareDx$69.85-2.9%Moderate Buy$70.33 0.7%91.3266 of 5 starsInsider Trade1.88%RGENRepligen$163.81-3.8%Moderate Buy$178.57 9.0%182.6964 of 5 stars1.83%GRALGRAIL$99.11-5.5%Hold$128.80 30.0%122.843 of 5 starsGap Down1.74%NBIXNeurocrine Biosciences$150.57-3.8%Moderate Buy$202.59 34.5%244.8908 of 5 stars1.74%CRLCharles River Laboratories International$314.29-4.2%Moderate Buy$311.67 -0.8%162.2602 of 5 stars1.43%JAZZJazz Pharmaceuticals$230.40-2.6%Moderate Buy$294.25 27.7%204.7191 of 5 stars1.21%PRAXPraxis Precision Medicines$300.43-3.4%Moderate Buy$660.50 119.9%223.1519 of 5 starsNews CoverageAnalyst Upgrade1.17%KNSAKiniksa Pharmaceuticals International$93.89+0.4%Moderate Buy$102.38 9.0%103.4545 of 5 starsAnalyst Forecast1.13%RPRXRoyalty Pharma$68.47+1.1%Buy$65.00 -5.1%93.5413 of 5 starsAnalyst ForecastInsider Trade This page (BATS:HELX) was last updated on 11/21/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.